"10.1371_journal.pone.0072934","plos one","2013-09-09T00:00:00Z","Peter Stenvinkel; Ole Fröbert; Björn Anderstam; Fredrik Palm; Monica Eriksson; Ann-Christin Bragfors-Helin; Abdul Rashid Qureshi; Tobias Larsson; Andrea Friebe; Andreas Zedrosser; Johan Josefsson; My Svensson; Berolla Sahdo; Lise Bankir; Richard J Johnson","Division of Renal Medicine, Department of Clinical Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, University Hospital of Örebro, Örebro, Sweden; Department of Medical & Health Sciences, Experimental Renal Medicine, Linköping University, Linköping, Sweden; Zoologisches Institut, Goethe-Universität, Frankfurt am Main, Germany; Faculty of Arts & Sciences, Department of Environmental & Health Studies, Telemark University College, Porsgrunn, Norway; Institute for Wildlife Biology & Game Management, University for Natural Research & Life Sciences, Vienna, Austria; Department of Nephrology, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, School of Health and Medical Sciences, Örebro University, Örebro, Sweden; INSERM Unit 872-E2, Centre de Recherche des Cordeliers, Paris, France; Division of Renal Diseases and Hypertension, University of Colorado Denver, Denver, Colorado, United States of America","Conceived and designed the experiments: OF AF AZ JJ MS BS. Performed the experiments: BA ME ACB. Analyzed the data: PS BA LB RJ. Contributed reagents/materials/analysis tools: PS TL BA ARQ. Wrote the paper: PS OF FP TL AZ LB RJ.","Dr. Johnson is listed as an inventor on two patents related to lowering uric acid as a means for treating hypertension (Treatment for Cardiovascular Disease US Patent No 7,799,794 B2, Issued Sep 21, 2010) or insulin resistance (Compositions and Methods for Treatment and Prevention of Insulin Resistance Serial No. 11/572,270; filed January 18, 2007 Serial No. 11/572,270; filed January 18, 2007, approved June 23, 2013). He also has patent applications related to blocking fructokinase in metabolic diseases. He has received funding from the NIH, State of Colorado, Danone, Questcor and Amway, and is on the Scientific Board of Amway. He has two lay books (The Sugar Fix, Rodale, 2008 and The Fat Switch, Mercola.com, 2012). None of these declarations are relevant to the current study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Peter Stenvinkel","PS",15,TRUE,6,3,4,7,TRUE,TRUE,FALSE,0,NA,FALSE
